These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 30354907

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, Abu-Rustum NR, Hricak H, Sala E.
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy.
    Onal C, Guler OC, Reyhan M, Yapar AF.
    Gynecol Oncol; 2015 Apr; 137(1):40-6. PubMed ID: 25641567
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
    Yilmaz B, Dağ S, Ergul N, Çermik TF.
    Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
    Cima S, Perrone AM, Castellucci P, Macchia G, Buwenge M, Cammelli S, Cilla S, Ferioli M, Ferrandina G, Galuppi A, Salizzoni E, Rubino D, Fanti S, De Iaco P, Morganti AG.
    Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
    [Abstract] [Full Text] [Related]

  • 14. Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.
    Surov A, Meyer HJ, Schob S, Höhn AK, Bremicker K, Exner M, Stumpp P, Purz S.
    Oncotarget; 2017 Apr 25; 8(17):28285-28296. PubMed ID: 28423698
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High standardized uptake values of 18F-FDG PET/CT imaging but not MRI correlates to pathology findings in patients with cervical cancer.
    Yang Z, Wu JR, Wei LL, Liao GX, Yang CJ, Jin GQ, Xiao GY, Su DK.
    Hell J Nucl Med; 2019 Apr 25; 22(2):96-102. PubMed ID: 31273350
    [Abstract] [Full Text] [Related]

  • 17. Maximum standardized lymph node uptake value could be an important predictor of recurrence and survival in patients with cervical cancer.
    Nakamura K, Joja I, Nagasaka T, Haruma T, Hiramatsu Y.
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb 25; 173():77-82. PubMed ID: 24275232
    [Abstract] [Full Text] [Related]

  • 18. (18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.
    Scher N, Castelli J, Depeursinge A, Bourhis J, Prior JO, Herrera FG, Ozsahin M.
    Cancer Radiother; 2018 May 25; 22(3):229-235. PubMed ID: 29650390
    [Abstract] [Full Text] [Related]

  • 19. Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma.
    Hong CM, Park SH, Chong GO, Lee YH, Jeong JH, Lee SW, Lee J, Ahn BC, Jeong SY.
    Cancer Imaging; 2019 Jun 24; 19(1):43. PubMed ID: 31234933
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
    Chong GO, Jeong SY, Park SH, Lee YH, Lee SW, Hong DG, Kim JC, Lee YS, Cho YL.
    PLoS One; 2015 Jun 24; 10(9):e0137743. PubMed ID: 26368542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.